Abstract:Introduction Short-chain fatty acids (SCFA) are bacterial metabolites that, within microbiome-gut-brain axis, make a promising research line on etiopathology of mental diseases like schizophrenia (SZ) and major depression disorder. Besides, depressive symptoms are frequent clinical features of SZ. Objectives - Describe fecal SCFA concentrations in SZ patients. - Analyze differences in SCFA depending on: - Depression. - Clinical severity, antipsychotics and antidepressants, comorbidities (pro-inflammatory state/obesity/metabolic syndrome [MetS]), lifestyle. Methods Cross-sectional study of 67 outpatients [mean age=43.52±12.42, range=22-67; males=40 (59.7%)] with diagnosis (DSM-5) of SZ recruited from their mental health clinics in Oviedo (Spain). - Assessment: - Fecal SCFA (gas chromatography;μg/mL). - Plasmatic C-reactive protein (CPR;mg/dL). - PANSS, Calgary Depression (CDS), International Physical Activity (IPAQ), Mediterranean Diet Adherence (MEDAS). - Toxic habits (alcohol use/smoking/cannabis). - Chlorpromazine equivalent doses (CPZ-ED), use of antidepressants. - MetS (ATP-III), body mass index (BMI; kg/cm2). - Statistics: Spearman correlation, U Mann-Whitney, ANCOVA. Results 14 patients showed clinical depression (CDS≥5). There were no differences in age or sex between groups. 36 patients (53.7%) showed systemic low-grade inflammation (CPR≥0.3mg/dL) and 32 (30.8%) MetS.Table 1 shows fecal SCFA levels by depressive state. Means (SD) are ahown. Table 1 CDS≤4 CDS≥5 Total U Mann-Whitney (p-value) Acetate 21.449(12.823) 12.911(7.189) 19.665(12.328) 221.000(0.021) Propanoate 9.170(6.819) 6.848(6.036) 8.685(6.687) 268.500(0.114) Butyrate 8.529(6.436) 7.875(8.232) 8.392(6.787) 320.000(0.432) Total SCFA 39.148(23.770) 31.415(24.526) 36.742(23.549) 250.000(0.062) Correlations were found in Age with Butyrate (r=-0.248,p=0.043) and weekly alcohol units with Propanoate (r=0.250,p=0.041) plus trend to significance with Butyrate (r=0.232,p=0.059). It also showed a trend towards statistical relation for CPZ-ED with Propanoate (r=-0.253,p=0.039) and Total SCFA (r=-0.253,p=0.039). We found no correlation in SCFA with MetS, CGI, PANSS-N, BMI, IPAQ, MEDAS and other toxic habits. ANCOVA was performed to Acetate and Total SCFA using depression state as independent variable and Age and CPZ-ED as covariates. There was a trend towards statistical significance for Acetate (F=3.937,p=0.052,η2=0.059) whereas Total SCFA showed no difference (F=1.350,p=2.250,η2=0.021). Conclusions There seems to be lower levels of fecal Acetate in SZ patients with depressive symptoms, considering age and antipsychotic intake. In our sample there was no relation between SFCA and clinical severity, lifestyle, comorbidities or antidepressant use. Disclosure of Interest None Declared

Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors

The Potential Role of SCFAs in Modulating Cardiometabolic Risk by Interacting with Adiposity Parameters and Diet

Implications of SCFAs on the Parameters of the Lipid and Hepatic Profile in Pregnant Women

Microbiota and SCFA in Lean and Overweight Healthy Subjects

Association between Serum Fatty Acids Profile and MetScore in Women with Severe Obesity

The Associations of SCFA with Anthropometric Parameters and Carbohydrate Metabolism in Pregnant Women

Abundance of Gut Microbiota, Concentration of Short-Chain Fatty Acids, and Inflammatory Markers Associated with Elevated Body Fat, Overweight, and Obesity in Female Adolescents

Microbiota Features Associated With a High-Fat/Low-Fiber Diet in Healthy Adults

Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans

Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis

Circulating Short-Chain Fatty Acids Are Positively Associated with Adiposity Measures in Chinese Adults

Decreased Microbial Co-Occurrence Network Stability and SCFA Receptor Level Correlates with Obesity in African-origin Women

Gut Microbiota Profile and Its Association with Clinical Variables and Dietary Intake in Overweight/Obese and Lean Subjects: A Cross-Sectional Study

Higher total faecal short-chain fatty acid concentrations correlate with increasing proportions of butyrate and decreasing proportions of branched-chain fatty acids across multiple human studies

Short-chain fatty acids in schizophrenia: are they affected by a depressive state?

2276-PUB: Fecal Profile of Short-Chain Fatty Acids: Associations with Environmental Factors in the First Year of Life of Women Participating in the Nutritionist’s Health Study

Altered levels of fecal short-chain fatty acids are associated with subclinical inflammation and worse cognitive performance in patients with schizophrenia

Analysis of Fecal Short-Chain Fatty Acids (SCFAs) in Healthy Children during the First Two Years of Life: An Observational Prospective Cohort Study

Comparison of the Activity of Fecal Enzymes and Concentration of SCFA in Healthy and Overweight Children

Higher Inflammation Is Associated with Cardiometabolic Phenotype and Biochemical Health in Women with Obesity

The role of short-chain fatty acids on insulin sensitivity: a systematic review and meta-analysis